Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Anaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01191749
What this trial is testing

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00072475
What this trial is testing

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Alliance for Clinical Trials in Oncology 155
Testing effectiveness (Phase 2)Study completedNCT00795132
What this trial is testing

Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

Who this might be right for
Acute LeukaemiaChronic DiseaseLeukemia+2 more
University of Utah 47
Early research (Phase 1)Study completedNCT00006098
What this trial is testing

PS-341 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT01928537
What this trial is testing

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Who this might be right for
Myelodysplastic SyndromesRefractory Anemia With Excess BlastsChronic Myelomonocytic Leukemia+1 more
Traws Pharma, Inc. 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT05600894
What this trial is testing

Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeMyelodysplastic Syndrome With Excess Blasts+2 more
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Testing effectiveness (Phase 2)UnknownNCT00895739
What this trial is testing

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Who this might be right for
Nonmalignant Neoplasm
Federico II University 50
Testing effectiveness (Phase 2)Study completedNCT01203722
What this trial is testing

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)Ended earlyNCT00119600
What this trial is testing

AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

Who this might be right for
AnemiaCancer
Amgen
Testing effectiveness (Phase 2)Study completedNCT00301834
What this trial is testing

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaDiamond-blackfan AnemiaLeukemia+2 more
University of California, San Francisco 35
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Not applicableStudy completedNCT00701844
What this trial is testing

Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

Who this might be right for
LeukemiaAcute LeukemiaAcute Lymphocytic Leukemia+3 more
University of North Carolina, Chapel Hill 315
Not applicableLooking for participantsNCT06947044
What this trial is testing

Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding

Who this might be right for
Acute LeukemiaAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukaemia
Donald Arnold 60
Not applicableStudy completedNCT04246021
What this trial is testing

Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy

Who this might be right for
AnemiaCancer
King Hussein Cancer Center 84
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Ended earlyNCT00931606
What this trial is testing

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Who this might be right for
Chemotherapy Induced Anemia
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Ended earlyNCT00210730
What this trial is testing

The Duration Study

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Testing effectiveness (Phase 2)Study completedNCT00266617
What this trial is testing

Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy

Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 86
Testing effectiveness (Phase 2)Study completedNCT00719888
What this trial is testing

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more
Fred Hutchinson Cancer Center 135
Next Page